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ABSTRACT
Epidemiological data reveal that schizophrenia is a major world public health problem. It affects approximately 
1% of the adult population, independently from sex and socio-cultural conditions. However, there are differences 
in gender concerning the onset and the development of this illness. Eighty patients with schizophrenia disorder 
(F20) by ICD-10, who had experienced a relapse of their illness, were assessed by the Rorschach technique. The 
results showed statistically significant genders differences in cognitive, affective and interpersonal interaction 
aspects. These results support earlier findings that found gender differences in schizophrenia: the disorder in male 
individuals tend to be more severe than in female, which affects adversely the behavior and social functioning of male 
patients. 
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RESUMO
As Diferenças entre os Gêneros na Esquizofrenia através da técnica de Rorschach
Dados epidemiológicos apontam que a esquizofrenia é um problema mundial de saúde pública de primeira grandeza. 
Atinge 1% da população adulta, independentemente de sexo e condições socioculturais. No entanto, há diferenças 
entre os gêneros quanto ao início e curso da doença. Foram avaliados por meio da técnica de Rorschach 80 pacientes 
diagnosticados com esquizofrenia (F20), de acordo com os critérios da CID-10, com recidiva da doença. Os resultados 
mostraram diferenças estatisticamente significativas entre os gêneros no que diz respeito aos aspectos cognitivos, 
afetivos e interação interpessoal. Esses resultados sustentam os achados de estudos anteriores que encontraram 
diferenças entre os gêneros na esquizofrenia: o distúrbio nos homens tende a ser mais grave do que nas mulheres, 
o que repercute de forma desvantajosa no comportamento e no funcionamento social desses pacientes do sexo 
masculino.
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RESUMEN
Las diferencias de género en la esquizofrenia en la técnica de Rorschach
Los datos epidemiológicos sugieren que la esquizofrenia es un problema mundial de salud pública de primera 
magnitud. Afecta a 1% de todos los adultos, independientemente del sexo y las condiciones culturales. Sin embargo, 
hay diferencias de género en relación con la aparición y el curso de la enfermedad. Fueron evaluados por la técnica 
de Rorschach 80 pacientes con diagnóstico de esquizofrenia (F20), de acuerdo a los criterios de la CIE-10, con la 
recurrencia de la enfermedad. Los resultados mostraron diferencias estadísticamente significativas entre géneros con 
respecto a la interacción cognitiva, afectiva e interpersonal. Estos resultados apoyan las conclusiones de estudios 
anteriores que las diferencias de género en la esquizofrenia: el trastorno en los hombres tiende a ser más severa que 
en las mujeres, lo cual afecta negativamente afecta el comportamiento y el funcionamiento social de los pacientes 
varones.
Palabras clave: esquizofrenia, las diferencias entre los géneros; técnica de Rorschach.280  Resende, A. C., Viglione, D. J. & Argimon, I. I. L
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Schizophrenia is a severe mental disorder, typically 
chronic, whose symptoms may be divided into three 
sub-syndromes:  positive  symptoms  (delusion  and 
hallucination),  which  are  the  absent  symptoms  in 
healthy individuals but present in schizophrenic ones; 
negative symptoms or absent in healthy individuals 
(affective  and  volitional  impoverishment);  and  the 
symptoms of disorganization that may be present in 
normal persons, however, they are more chaotic and 
severe  in  schizophrenic  people  (puerile  behavior, 
disorganized speech, cognitive and attention deficits 
and labile affect). Most of the evidences suggest that 
this disorder may involve a genetic predisposition that 
requires intrapsychic and interpersonal activation. This 
way, metabolic factors and environmental influences 
may  protect  or  unleash  the  symptoms  inherent  to 
this  illness  in  susceptible  persons  (APA,  2002; 
Lara, Gama and Abreu, 2004; Sadock and Sadock, 
2007).
Epidemiological data reveal that schizophrenia is 
a major world public health problem. In average, these 
patients hold 50% of all places in psychiatric hospitals. 
It affects approximately 1% of the adult population, 
independently from sex and socio-cultural conditions. 
However, there are differences in gender concerning 
the onset and the development of this illness. The onset 
is generally early in men, usually between 15 and 25 
years old. They are more likely to suffer from the 
negative symptoms, to remain single, commit suicide, 
have less quality of life, present problems related to 
drug use and criminal activity, as well as diminished 
social functioning, and resistance to efforts to treat 
the illness. For women, the onset of the illness is later. 
Many times, it is observed at the age of 25 or later, 
and for approximately 7% of these patients, the illness 
comes about after 40 years of age. In addition, these 
women, typically are married or divorced, and have 
children to take care of.  They suffer, what appears to 
be a more benign form of schizophrenia with a more 
adequate  social  functioning  and  a  more  favorable 
response  to treatments (Aleman, Kahn and Selten, 
2003; APA, 2002; Cardoso, Caiaffa, Bandeira, Siqueira, 
Abreu and Fonseca, 2006; Chaves, 2000; Grossman, 
Harrow, Rosen, Faull and Strauss, 2008; Sadock and 
Sadock, 2007; Kelly, 2006; Ran et al., 2009; Rãsãnen, 
Pakaslahti, Syvãlahti, Jones and Isohanni, 2000).
Johann,  Vaz  and  Derivi  (2004)  described  the 
Rorschach data (Klopfer System) of some patients in 
the city of Porto Alegre, and observed some differences 
between the sexes. Women gave the impression of 
being more capable of attending to their experience 
in a reasonably open and flexible manner than men. 
They likely avoided either oversimplifying situations 
that were truly complex or overcomplicating those 
that were quite simple. Depite this personality asset 
they demonstrated a severe impairment of their reality 
testing abilities. This significant adaptive liability was 
likely to result in their frequent failure to construe 
the  boundaries  of  appropriate  behavior  (F=42,0% 
and F-=46,5%). (F=42,0% and F-=46,5%). Female 
individuals presented a larger capacity to express their 
affection and feelings (ΣC=16,8%) but their affective 
discharges  were  more  intense  and  less  controlled 
(FC<CF+C), and they also showed fearful and tense 
relationships (M-=68,8% and M+=18,8%) than male 
individuals.  In  turn,  male  individuals  showed  less 
general control of their impulses and instincts, showing 
themselves more disorganized. However, they showed 
more  ability  on  logical  reasoning  (F=  26,4%  and 
F-=20,6%), more control of their affective discharges 
(FC=CF+C), although they rarely showed their feelings 
(ΣC=4,6%). As far as relationships, men were less tense 
and a little more empathic than women (M+=58,3% 
and M-=38,9%).
In scientific literature there are two studies where 
the  Rorschach  Comprehensive  System  (CS)  was 
used  to  examine  the  differences  between  genders 
in  schizophrenia.  Both  demonstrate  that  the  CS 
is  sensitive  to  subtle  differences  in  the  cognitive 
disturbances between men and women. In the first 
study, Perry and Braff (1995), in the United States, 
based on differences in the Ego Impairment Index 
(EII) found that schizophrenic male patients presented 
greater thought disturbances than female patients, who 
were more socially competent. The EII, generated from 
responses to Rorschach CS, is essentially a cognitive 
measure of disturbed thinking, the higher score in the 
male  group  entails  more  psychopathology,  thought 
disturbance (test of reality deficits, illogical reasoning), 
and object relations problems, as well as dysfunctional 
behavior and adaptation failures.
In contrast, Danielsson, Flyckt and Edman (2001), 
focusing on sex-related differences with the cognitive 
aspects of schizophrenia in Sweden, found a greater 
EII for women. This result implies on larger thought 
disturbance in the female group than in the male goup, 
but this difference was not statistically significant. The 
authors justified this divergence with the results of Perry 
and Braff (1995) because the two studies had used very 
different samples. The participants of the Perry study 
were older chronic patients, and received higher doses 
of neuroleptic drugs, while in the study of Danielsson 
et al. (2001), the participants were younger, and 50% 
of them only had the first episode of the illness. Thus, 
comparing results of the studies might be confounded. 
Consistent with other reports, these two studies might 
suggest that there is an interaction with age, or that age 
may moderate gender differences.Gender differences in schizophrenia through Rorschach technique  281
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Several studies prove that the differences between 
sexes are an important predictable factor in the course 
and  evolution  of  schizophrenia,  as  they  may  also 
contribute to the elaboration of strategies of treatment 
and planning of health services more appropriate to 
these patients (Aleman et al., 2003; Cardoso et al., 
2006; Chaves, 2000; Kelly, 2006; Rãsãnen et al., 2000). 
Besides these aspects, the Rorschach has demonstrated 
its  validity  in  identifying  the  differences  between 
genders  in  schizophrenia.  Accordingly,  this  study 
investigates whether similar differences also occur in 
a Brazilian population, in the form of personality traits 
assessed by the Rorschach technique. 
METHOD
Sample
Eighty patients, 40 men and 40 women, ages 20 
to 55 years with a schizophrenia diagnose (F20) by 
ICD-10 (WHO, 1993) participated in this study. At the 
time of the study they had experienced a relapse of 
their illness and were in psychiatric hospitals in the city 
of Goiânia-GO, Brazil. Most (70%, n=56) were being 
medicated with typical, incisive antipsychotics, such 
as Haloperidol. Those patients with a maniac episode 
(F30), or a depressive episode (F32), which occurred 
before the characteristic symptoms of schizophrenia, 
as well as those patients with observable brain disease, 
and those ones who  were in states of drug intoxication 
or withdrawal were excluded. The sample size (n=80) 
was statiscally determined in function of the prevalence 
of the illness in the population of Goiânia, i.e., 1% of 
1,200,000 inhabitants, considering that in average 50% 
of the patients present comorbidity with an abuse of 
alcoholic substances and other drugs (Volkow, 2009), 
and, therefore, they could not take part in this study. 
The participants constituted a purposive sampling. 
The researcher was aware of several psychiatric hospitals 
in the city and chose those that were typical and did 
her study with patients of those institutions. Then, case 
records of the patients at the Inpatient Departments 
were scanned initially to identify those who fulfill the 
study criteria. To calculate the minimum sample was 
applied the following formulas suggested by Barbetta 
(2004): n0 =1/e2  and n=N.n0/N+n0 [N=population size 
(6,000 schizophrenic patients), n=sample size, n0=a 
first  approximation  to  the  sample  size;  e=tolerable 
error, for this study 11% error approximately]. 
Instruments
The  psychiatrists  interviewed  the  patients  on 
the eight groups of ICD-10 signs and symptoms of 
schizophrenia noted their ratings on a form. The ICD-
10 is the World Health Organization’s (WHO) official 
classification of mental disorders and behavior, for 
clinical,  educational,  research  and  other  purposes. 
These psychiatrists who helped with the research are 
well-trained in the ICD-10 and routinely use it in their 
practice.
Rorschach Technique. It is a personality assessment 
technique based on an indviduals making sense of 10, 
internally inconsistent and ambiguous designs based 
on ink blots. Responses to the question, “What might 
this be?” because the subject is given no guidance from 
the examiner, are based on the cognitive, affective 
structure,  personal  and  interpersonal  imagery,  and 
concerns of the individual.  Scoring across the ten 
cards allows these factors to be quantified. The way the 
subject processes and structures the contradictory and 
ambiguos elements of the ink blot design reflects the 
way he or she proceses information in life, so that the 
Rorschach performance is generalizable to every day 
life. In this study, the classification and interpretation 
of the Klopfer system was adopted, as adapted and 
validated by Vaz (1997, 2006), but at times different 
interpretation systems were used where appropriate 
(Exner, 2003). The Rorschach variables analyzed for 
this study were grouped in terms of cognitive and 
affective, and interpersonal component as described in 
Table 1.
TABLE 1 
Rorschach variables distributed by groups referring 
to the cognitive and affective aspects, and 
interpersonal integration
Component Rorschach variables
Cognitive R, G%, D%, Dd%, F%, F-%, M, M-, Pop, 
Abstractions ΣSpecial Phenomena*, Type of 
Experience
Affective ΣC, FC<CF+C, Cn, ΣShaded, ΣC’, Affection 
Index, S, Type of Experience
Interpersonal  M, M-, FM, ΣH, H+A: Hd+Ad, 
H<(H)+(Hd)+Hd, Sex, At, Σc e Deterioration 
Comments
*  ΣSpecial Phenomena This summation response characteristics indicative 
of cognitive impairment or a tendency to reason in an unfounded or arbitrary 
way such as contamination, confabulation, rejection, self-reference, position 
responses, neologism and perseveration.
Patients’  Medical  Records.  They  are  used  to 
collect demographic and other relevant data including 
profession, age, school level, previous symptoms of the 
treatment and medication used before the Rorschach 
assessment. 
Procedures for collecting data
The board of directors of three psychiatric hospitals 
was contacted to procure their consent to implement this 
study. After the authorization from the director of each 
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the eligible patients according to the study’s inclusion 
and exclusion criteria. Also the researcher reviewed 
the patient’s medical report to further evaluate sample 
exclusion criteria. Before the assessment, we tried to 
contact each patient in order to invite and motivate them 
to participate in the research, as well as to obtain their 
and also their responsible party’s informed consent, 
according to standard ethics rules for research with 
human beings. 
In 75% of the cases (n=60), the Rorschach was 
administred after the psychiatrist’s completing ICD-
10  schizophrenia  form.  In  other  case,  a  maximum 
period of one week passed after the ICD-10 survey 
were completed. The Rorschach was administered in a 
standard fashion, following the instructions described 
by Vaz (1997), in appropriate hospital rooms. However, 
this was a complex task and involved techniques that are 
relatively uncommon with people free from psychotic 
disorders. In some cases we allowed short interruptions 
for questions, to rest, so as to continue with the test 
when the patiens were more attentive and motivated. 
After such intervals, 14 tests were not completed and 
were excluded from the sample. 
Procedures for data analysis 
The author of this article coded all the records. For 
the intercoder agreement, another psychologist, who 
did not know the objective of this study, but was also 
trained in the Klopfer Rorschach System (Vaz, 1997), 
coded 25% of the protocols (20 in total), selected at 
random.  Intercoder  agreement,  or  reliability,  was 
deteremined by the Kappa coefficient. It quantifies the 
reliability on an individual response score level taking 
into consideration chance agreement. Discrepancies 
were resolved by discussion between the two coders.
The male and female patients were compared on 
key demographic and Rorschach variables with the use 
of Student’s test for parametric data for instance for age, 
education, daily dose of medication, and for the  F%, 
G% and  D% variables, whereas Mann Whitney Tests 
were used for non parametric continuous measures, for 
exemple for Special Codes.  The Chi-square test was 
applied to nominal variables, for example, Rorschach 
Experience Type and presence of ICD-10 schizophrenia 
symptom  groups.  The  significance  level  used  was 
p≤0,05. All the analyses were conducted using the 
SPSS computer program, 12.0 version.
RESULTS AND DISCUSSION
Agreement level between judges
The Kappa coefficient between the two evaluators 
of the Rorschach techique varied between 0,86 and 
0,94  (p<0,001),  indicating  that  there  was  a  high 
agreement  between the judges and that the correction 
of the Rorschach technique for this study is considered 
reliable.  Interrater  reliability  satistics  are  provided 
in Table  2  for  the  basic  scoring  segments  of  each 
response. 
TABLE 2 
Rorschach interrater agreement on conding segments  
(n= 20 protocols, total resposes= 269)
Categorias Kappa P
Location 0,94 <0,001
Determinant 0,86 <0,001
Contents 0,89 <0,001
Popular 0,92 <0,001
Special Codes 0,86 <0,001
Clinical assessments and demographic data
Eighty  people  with  an  ICD-10  diagnosis  of 
schizophrenia participated in this study, 50% were 
men and 50% were women. Among the men, 17,5% 
(n=7)  were  married,  82,5%  (n=33)  were  single, 
divorced or separated. Among the women, 30% were 
married (n=12), 70% were single, divorced, separated 
or  widows.  Some  comparisons  of  the  clinical  and 
demographic assessments are presented in Table 3. 
Significant differences between genders were found 
in the variables: age and group of Symptoms 2 for 
schizophrenia.The  other  variables  (years  of  study, 
medication dose of Haloperidol type and the other 
groups  of  Symptoms  –  1,3,4,5,6,7  and  8  did  not 
highlight  significant  differences  between  men  and 
women. 
TABLE 3 
Differences between genders for clinical and  
demographic variables (n=80) 
Clinical and 
demographic variables
Men 
(n=40)
Women  
(n=40) Sig
Mean SD Mean SD
Age 36,43 10,76 40,73 7,98 ,041**
Education (years) 7,42 3,23 6,41 2,34 ,087
Haldol dose mg/day* 10,12 4,91 9,30 4,06 ,885
F20 Symptom Group 1  0,30 0,46 0,30 0,46 1,00
F20  Symptom Group 2 0,38 0,49 0,65 0,48 ,016**
F20 Symptom Group 3 0,35 0,48 0,43 0,50 , 500
F20 Symptom Group 4 0,38 0,51 0,28 0,45 ,069
F20 Symptom Group 5 0,43 0,50 0,35 0,48 ,489
F20 Symptom Group 6 0,08 0,27 0,15 0,36 ,293
F20 Symptom Group 7 0,13 0,34 0,10 0,30 ,732
F20 Symptom Group 8 0,63 0,49 0,45 0,54 ,102
** Variable observed only in 70% of the sample (n=56, 22 men and 24 women), 
  that used this medication.
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According to data in Table 3, it can be noted that 
men were significantly younger than women. Regarding 
age, it is known that the sooner the disease is detected 
the worst the prognosis. A late onset of schizophrenia 
is a positive or protective factor, because when the first 
episode happens at a later age it helps the patient to 
better develop his abilities and social experiences before 
the disease, as well as to acquire more knowledge, 
and probably, to have a larger internal resilience and 
resistance to the psychopathology (Grossman et al., 
2008). The significant older age of the female group 
suggests this protector factor in those patients, but 
unfortunately onset dates were not available in this 
study.
The  women  also  revealed  that  they  suffered 
expressively more than the men of the second group 
of typical symptoms of schizophrenia delusions of 
control,  influence  or  passivity,  clearly  referred  to 
body or limb movements or specific thoughts, actions, 
or  sensations;  delusional  perception.  Many  times 
the patient with these symptoms feels like a passive 
victim of imperative voices or strange cenesthesia. In 
women, these cenesthesic complaints are often located 
mainly  in  the  genital  organs;  they  complain  about 
being victims of sexual intercourse, sexual assault, and 
masturbation. Such cenesthesic delusion phenomena are 
also frequently considered persecutory (Paim, 1991).
It is probable that these delusion symptoms may be 
responsible for part of the damages that the women of 
this study demonstrated in the capacity of relationship, 
becoming more anxious, tense and inadequate during 
relations with other, causing undesirable situations in 
social integration. This type of delusion may also be 
considered as a system of relations that neglect the 
reality principle and that conducts to the creation of 
a new reality that, in the case of the women of this 
study, may translate the intense sexual anxiety that are 
expressed in a chaotic way. 
On their turn, men seem to suffer more from ICD 
Symptom Group 8 – “negative” symptoms. This group 
of symptoms, expressed by a global impoverishment of 
the psychic and social life of the patient, do not respond 
well to neuroleptic medication and make it difficult to 
establish  the  initial  schizophrenia  diagnosis. These 
symptoms are often confused with depression, so as to 
confuse judgments about the medication. Differently, 
the  group  of  symptoms  2,  better  administered  by 
the  neuroloptic  medication,  which  affects  women 
significantly,  is  part  of  the  positive  symptoms  of 
the disease which are flowery and productive in the 
schizophrenic process. They appear as an exaggeration 
or intensification of psychic functions, and they are easily 
detectable as classic so as to aid accurate diagnosis. In 
contrast to negative symptoms and group 2 symptons 
they make early identification of the disorder easier. In 
contrast to the men, the group of women in this study 
had a more benign form of schizophrenia.
In  Table  4  the  cognitive  Rorschach  variables 
are  presented.  Table  5  containts  Experience  Type 
(Erlebnistypus) results.
TABLE 4 
Differences between genders for cognitive  
Rorschach variables 
Rorschach cognitive 
variables
Men  
(n= 40)
Women  
(n= 40) Sig
Mean SD Mean SD
R 13,63 8,14 13,93 5,47 ,847
G% 50,98 29,42 64,30 26,36 ,036*
D% 33,00 14,94 32,09 18,06 ,899
Dd% 36,17 24,5 21,96 18,19 ,004**
F% 66,75 14,80 58,63 15,30 ,018*
F-% 50,28 30,49 54,08 28,24 ,565
M 0,88 1,37 1,30 1,92 ,147
M- 0,90 1,24 1,03 1,59 ,227
FM 1,02 1,10 1,15 1,42 ,661
Abstraction 0,78 1,38 0,78 1,40 1,00
ΣSpecial Phenomena 11,33 7,98 7,93 4,66 ,048*
** Significant difference  p<0.05.
** Significant difference  p<0.01
TABLE 5 
Chi-square contrasts of Rorschach Experience Type 
by gender
Types of experience Male Female Sig
Coarctated 26 16 ,043*
Introversive 6 14 ,069
Extratensive 8 10 ,790
Total 40 40
* Significant difference  p<0.05.
Tables 5 and 6 show that there are statistically 
significant  differences  among  the  patients  with 
schizophrenia from the male and female sex in the 
Dd%,  F%  variables,  Experience  Type  Coarctative 
and ΣSpecial Phenomena, all of them with a higher 
frequency level among men, and in the G% variable that 
was higher among women. These data indicate that not 
only male patients, but also the female ones presented 
diffuse  attention  (Dd%men=36,17,  Dd%women=21,96) 
and used inconvenient generalizations G%men=50,98, 
G%women=64,30).  In  general,  this  is  the  way 
schizophrenic patients collect and process information. 
However, the male patients were the ones that worried 
the most with more insignificant and detailed aspects 
of the stimulus (Dd% 36,17, p<0.01).  When directing 
their attention to the surroundings, they had less ability 
to ignore distracting stimuli, showing themselves more 
incoherent and insecure than female patients.284  Resende, A. C., Viglione, D. J. & Argimon, I. I. L
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It was also observed that men with schizophrenia 
tend to simplify complex situations more, searching for 
simpler, superficial, and more disengaged solutions for 
their problems (F%=66,75, p<0.01). At the same time, 
they  demonstrated  more  frequently  the  Coarctated 
Experience Type (p<0.05), which is a characeristic of 
a person with limited imagination and psychological 
resources to call in coping situations. These findings 
together, herefore, showed that men were less capable 
of adaptation than women. Besides, the greater Special 
Phenomena score for men shows that they demonstrate 
more  illogic  and  disturbed  thinking  and  problem-
solving, tending to reason in an arbitrary and disconnect 
way, as well as being more inclined to irrelevant revery   
that undermines others’ understanding them. Thus, in 
a general way, the male patients with schizophrenia 
presented a more severe disturbance than the female 
patients. They reasoned in a more superficial, rigid and 
incoherent way (Dd%, F% index, Type of Coarctative 
experience  and  higher  Σspecial  phenomena)  than 
female individuals with the same disorder. The female 
patients  showed  a  larger  more  inclusive  problem-
solving style, with more ability to think flexibility 
and  elaborate  mentally.  They  also  demonstrated  a 
richer fantasy life. (High G%, lower F%, M and Type 
of introversive experience slightly less frequent than 
male patients). These differences allow us to conclude 
that  women  with  schizophrenia  in  our  sample  had 
more access to the complex psychological resources, 
demosntrating less cognitive damages than the men.
Table 6 presents the affective Rorschach variables. 
The  ΣC  variable  was  significantly  higher  among 
women, while in men the White Space variable (S) 
showed itself as more frequent. These data suggest that 
women with schizophrenia showed a better capacity to 
live and express affect than men, thus suggesting less 
limitations in adaptation (ΣCmen=1,21, ΣCwomen=1,45, 
p<0.05). 
On  the  other  hand,  male  patients  excelled  for 
presenting  more  situational  anxiety  ((Smen=1,35 
e  Swomen=0,65,  p<0,05),  according  to  Vaz  (1997). 
According  to  Exner  (1999),  the  increase  of  the  S 
variable reveals opposing tendencies that go beyond 
adaptive  autonomy  and  that  associates  itself  to 
underlying feelings of anger and resentiment against 
people and events of their lives. In this case, the male 
group, more than the female one, tend to feel unfair the 
fact of not answering to their needs or raise obstacles 
in the achievement of their goals. This fact interferes 
in the delightful and affection experience, as well as 
it generates problematic and hostile behaviors that do 
not solve the problems. It may be inferred that there is 
a higher predisposition in the male group to react in a 
more agressive way to situations – this aspect was also 
highlighted in the study made by Weiss, Marksteiner, 
Hinterhuber and Nolan (2006). Besides, the affect of 
the male patients are slightly blunter and with more 
sadness (ΣC’men=1,40 e ΣC’ somen=0,95), and they also 
expressed  more  intense  affection  disorders,  typical 
psychotic  or  organic  deterioration  (Cnmen=0,70  e 
Cnsomen=0,18). 
TABLE 6 
Differences between genders for affective  
Rorschach variables
Rorschach cognitive 
variables
Men  
(n= 40)
Women  
(n= 40) Sig
Mean SD Mean SD
ΣC  1,21 2,54 1,45 1,28 ,029*
FC<CF+C – – ,081
Cn 0,70 1,71 0,18 0,50 ,132
Σshaded 1,71 1,04 1,45 0,85 ,141
ΣC’ 1,40 1,94 0,95 1,19 ,217
Affective Ratio 0,29 0,08 0,28 0,10 ,898
S 1,35 1,92 0,65 0,94 ,043*
* Significant difference p<0.05.
These data, in consonance with the studies, reveal 
that the women with schizophrenia who participated 
in this study have superior affective adaptation, with 
more satisfying and enjoyable affective experiences 
compared to the the men diagnosed with the same 
disease. 
On what concerns the capacity of interpersonal 
integration, Table 7 points out the Sex and  Σc variables 
as significantly more common among women than men 
with schizophrenia.
TABLE 7 
Differences between genders for interpersonal  
Rorschach variables
Interpersonal variables
Men 
(n= 40)
Women 
 (n= 40)
Sig
Mean SD Mean SD
ΣH (H+(H)+(Hd)+Hd) 3,00 3,11 2,93 2,77 ,910
H<(H)+(Hd)+Hd 29 frequencies 26 frequencies ,753
Sex 0,40 1,00 1,45 1,52 ,005**
Deterioration comments 2,30 1,88 3,10 2,93 ,433
Σc 0,15 0,42 0,40 0,59 ,036*
** Significant difference  p< 0.05.
** Significant difference  p< 0.01.
The Rorschach Sex variable indicates that women 
presented more somatic concern, particularly related 
to sexuality (Sexmen=0,40 e Sexwomen=1,52, p<0,01). 
Additionally,  these  sex  responses  in  conjunction 
with symptom group 2 findings, suggest that women Gender differences in schizophrenia through Rorschach technique  285
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might  more  often  experience  sexualized  content 
within  misinterpretions  of  reality,  idiosyncratic 
preoccupations, delusions and hallucinations. These 
might be more frequent among women. However, due 
to the simple fact that it is a more intense concern for 
these patients, the treatment should integrate not only 
a safer sanctuary for sexual anguish, but also should 
consider sexual education as an important part in these 
disease interventions.
Besides  these  bodily  concerns,  these  patients 
demonstrated  more  need  for  affection  and  social 
contacts  than  men  (Σcmen=0,15  e  Σcwomen=0,40, 
p<0,05). Probably, this is the aspect that make women 
more inclined to establish intimate closer relations, 
and support than male patients. Again, the data show 
that these women are more engaged in life. However, 
considering  the  various  aspects  assessed  by  other 
variables,  it  is  noticed  that,  relative  to  normative 
expectations, the two groups tend to direct their attention 
to themselves and to the other with the same frequency 
(ΣH without significant difference between the groups), 
and both are characterized by their limited capacity to 
understand themselves and others (H<(H)+(Hd)+Hd), 
with a less comprehensive and more fantasy-based 
self-image and perception of the others. This distorted 
perception causes an emotional unease and discomfort 
in the interpersonal relationships and makes social 
relations difficult to establish and maintain. 
FINAL CONSIDERATIONS
This  study  addressed  gender  differences  in 
schizophrenia, which had not been attempted in Brazil, 
with Klopfer and Vaz Rorschach technique. They support 
previous studies that male patients demonstrated more 
severe cognitive disorders, greater affective deficits, 
and more negative symptoms of the disease. All of 
these harms the male patients’ interpersonal relations, 
more than with female patients. To further evaluate 
these  findings  it  would  be  interesting  to  conduct 
longitudinal studies involving different phases of the 
disease process and the patient’s treatment. It may be 
interesting to develop a future research relating age 
to Rorschach variables and compare it to the present 
study that focus on gender. 
Other  factors,  undoutedly,  are  related  to  these 
gender  differences  in  schizophrenia.  These  gender 
specific  aspects  probably  include  genetic,  prenatal, 
developmental, and hormonal factors, differences in 
cerebral structure, differences in social expectations, 
social support systems  , among other factors that have 
been addressed in the literature about schizophrenia 
(Andersen, Gade, Fagerlund, Orange and Glenthoj, 
2009; Goldstein et al., 2009; Grossman et al., 2008; 
Mancini-Marie et al., 2009;  Mendrek et al., 2009; 
Werf, Boydell, van Os, Murray and Allardyce, 2009).
It should also highlighted that the Rorschach gender 
differences observed in our study are not observed 
between  genders  in  the  Rorschachs  in  the  general 
population. The Rorschach normative data incorporate 
very little differences between men and women (Exner, 
2003, Nascimento, 2007; Vaz, 1997, 2006). Therefore, 
the differences found between genders may be effects 
induced, partly, by the disease itself.
In  this  investigation,  additional  aspects  related 
to  gender  are  highlighted.  Men  were  significantly 
younger  than  women,  and  tended  to  reason  in  a 
simpler, superficial and incoherent way. They were less 
emotionally expressive and engaged and more affetively 
constriced, but showed more situational anxiety and 
sadness along with a predisposition to hostile behaviors. 
Women  with  schizophrenia,  besides  apparently 
manifesting the disease at a later date, were more likely 
to be married, and were more likely to experience 
positive symptoms in the form of delusions of control, 
influence or passivity, as well as concerns related to 
their body and sexuality. They felt freer to express their 
feelings and thoughts, and to seek out close relations. 
Compared  to  negative  symptoms,  their  positive 
symptoms may help in the accurate identification of 
the disease and may be more responsive to neuroleptic 
medication. All these gender differences, taken together 
make schizophrenia in the female sex a more benign 
form of the disease than for male sex.
This research demontrates that the Rorschach is  a 
useful technique for the study of genders differences 
in schizophrenia expressed in cognitive and affective 
processes, self-perception and interpersonal relations. 
This type of information accessed by the Rorschach 
is  not  easily  assessed  by  psychological  interviews 
with these patients with schizophrenia. In face of what 
was exposed in this study, it is understood that the 
differences between genders in schizophrenia must be 
considered not only during psychological investigations, 
but must be integrated with the treatment program of 
people assailed by this disease. Treatment strategies 
recognizing the differential impact of the disease on 
men and women might contribute to more appropriate 
community health service plans, make treatment more 
effective, and minimize relapse.
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